Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase

  • Science. 1998 May 22;280(5367):1262-5. doi: 10.1126/science.280.5367.1262.
M Camps  1 ,  A Nichols ,  C Gillieron ,  B Antonsson ,  M Muda ,  C Chabert ,  U Boschert ,  S Arkinstall
Affiliations
  • 1. Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., CH-1228 Plan-les-Ouates, Geneva, Switzerland.
Abstract

MAP kinase phosphatase-3 (MKP-3) dephosphorylates phosphotyrosine and phosphothreonine and inactivates selectively ERK family mitogen-activated protein (MAP) Kinases. MKP-3 was activated by direct binding to purified ERK2. Activation was independent of protein kinase activity and required binding of ERK2 to the noncatalytic amino-terminus of MKP-3. Neither the gain-of-function Sevenmaker ERK2 mutant D319N nor c-Jun amino-terminal kinase-stress-activated protein kinase (JNK/SAPK) or p38 MAP Kinases bound MKP-3 or caused its catalytic activation. These Kinases were also resistant to enzymatic inactivation by MKP-3. Another homologous but nonselective Phosphatase, MKP-4, bound and was activated by ERK2, JNK/SAPK, and p38 MAP Kinases. Catalytic activation of MAP kinase phosphatases through substrate binding may regulate MAP kinase activation by a large number of receptor systems.